Good morning, everyone. Here are the five things you need to know in Boston business news to start your Wednesday.
A Flagship Pioneering-backed biotech behind one of the only new drugs in development for long Covid is closing its doors, Rowan Walrath reports.
Rowan also reports that serial entrepreneur Gary Glick's latest startup has $101 million in fresh funds as it marches toward human trials, starting with gastrointestinal disease.
A highly-anticipated hearing between Cannabis Control…
